Real-time enrollment status for this cancer clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:13 AM UTC
| NCT Number | NCT05565417 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 151 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Immunitas Therapeutics |
| Last Updated on CT.gov | October 16, 2025 (Oct 16, 2025) |
As of March 2, 2026: Clinical trial NCT05565417 is currently active_not_recruiting participants. This clinical trial study for cancer is not currently accepting new participants at 10 locations across the United States. The study is sponsored by Immunitas Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05565417 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05565417 was last updated Oct 16, 2025 (October 16, 2025). HelloStudys verifies this status automatically.